Archive for the 'Fentanyl' Category



Police looking for woman accused of stealing from nursing home patients (The Huntsville Times)

Tuesday 6 January 2009 @ 3:03 pm
Madison PoliceJanice Frost Wells, 39, is accused of stealing a pain patch from a nursing home patient. MADISON, Ala. -- Investigators are looking for a woman who has been allegedly sneaking into nursing homes and stealing pain patches from patients....



Hostage standoff, massive manhunt captured headlines (Suburban Journals)

Tuesday 6 January 2009 @ 3:38 am
A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.



Ym Biosciences Receives Clearance to Initiate Randomized Double-Blind Clinical Trials of Nimotuzumab in Lung Cancer … (PR Newswire via Yahoo! Finance)

Monday 5 January 2009 @ 5:00 pm
YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has received clearance from Canadian regulatory authorities to initiate two Phase II, double-blind, randomized trials for nimotuzumab, its EGFR-targeting antibody, in combination with radiation-based treatments.



YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER … (CNW Group via Yahoo! Finance)

Monday 5 January 2009 @ 5:00 pm
YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has received clearance from Canadian regulatory authorities to initiate two Phase II, double-blind, randomized trials for nimotuzumab, its EGFR-targeting antibody, in combination with radiation-based treatments.



YM BIOSCIENCES’ NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE (CNW Group via Yahoo! Finance)

Monday 5 January 2009 @ 7:00 am
YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that the National Cancer Centre of Singapore has selected nimotuzumab, YM's EGFR-targeting drug, for evaluation in a multinational Phase III trial of more than 700 patients with cancers of the head and neck.



BioDelivery Sciences Closes $6 Million Transaction with Meda (Centre Daily Times)

Monday 5 January 2009 @ 6:26 am
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) and Meda AB today announced an expansion of their commercial partnership that provides Meda with worldwide exclusive rights to distribute the company’s lead product candidate ONSOLIS™, a treatment for breakthrough pain in opioid tolerant patients with cancer. The transaction will give Meda exclusive rights to distribute ONSOLIS in all ...



BioDelivery Sciences Closes $6 Million Transaction with Meda (Business Wire via Yahoo! Finance)

Monday 5 January 2009 @ 6:00 am
RALEIGH, N.C.----BioDelivery Sciences International, Inc. and Meda AB today announced an expansion of their commercial partnership that provides Meda with worldwide exclusive rights to distribute the company’s lead product candidate ONSOLIS™, a treatment for breakthrough pain in opioid tolerant patients with cancer.



PriCara recalls 50mcg/hr Duragesic CII pain patches (Pharmaceutical Business Review)

Monday 5 January 2009 @ 5:56 am
PriCara, a division of Ortho-McNeil-Janssen Pharmaceuticals, has announced that one lot of 50mcg/hr Duragesic CII patches sold by PriCara in the US and one lot of 50mcg/hr fentanyl patches sold by Sandoz in the US are being voluntarily recalled as a precaution from wholesalers and pharmacies.



Hostage standoff, massive manhunt captured headlines (Suburban Journals)

Monday 5 January 2009 @ 3:36 am
A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.



Hostage standoff, massive manhunt captured headlines (Suburban Journals)

Sunday 4 January 2009 @ 3:17 am
A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.



«« Previous Posts